TE_38983
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR10F |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | TTTY14 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.26 |
| Counts of samples | TCGA_tumor:141; TCGA_normal:10; GTEx:601 |
| TSS | chrY(-):19041802 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38983.1 | TTTY14 | Chimeric | Non-coding | Non-coding | chrY(-):18773353,18773373,18789811,18789919,18790570,18790767,18819355,18819786,18828585,18828719,18830436,18830639,18833002,18833103,18833756,18836407,18838752,18838872,18839182,18839313,18877068,18877205,19041370,19041552,19041752,19041803 |
| teRNA_38983.2 | TTTY14 | Chimeric | Non-coding | Non-coding | chrY(-):18773353,18773373,18790570,18790767,18813616,18813743,18819355,18819786,18828585,18828719,18830436,18830639,18872444,18872834,18877068,18877205,19041370,19041552,19041752,19041803 |
| teRNA_38983.3 | TTTY14 | Chimeric | Non-coding | Non-coding | chrY(-):18807445,18807465,18813616,18813743,18819355,18819460,18819554,18819786,18828585,18828719,18830436,18830639,18833002,18833103,18833756,18836407,18838752,18838872,18839182,18839313,18877068,18877205,19041370,19041552,19041752,19041803 |
| teRNA_38983.4 | TTTY14 | Chimeric | Non-coding | Non-coding | chrY(-):18872814,18872834,18877068,18877205,19041370,19041552,19041752,19041803 |
| teRNA_38983.5 | TTTY14 | Chimeric | Non-coding | Non-coding | chrY(-):18773353,18773373,18790570,18790767,18813616,18813743,18819355,18819786,18828585,18828719,18830436,18830639,18872444,18872834,18877068,18877205,19041370,19041586,19041752,19041803 |
| teRNA_38983.6 | TTTY14 | Chimeric | Non-coding | Non-coding | chrY(-):18872814,18872834,18877068,18877205,19041370,19041586,19041752,19041803 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
